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he recent Ebola outbreak in Western Africa taught us that Ebolaviruses 
can cause much larger outbreaks and represent a much greater health 
threat than many of us believed (or wanted to believe). As of 30th March, 
the outbreak had resulted in 28,646 conirmed cases and 11,323 deaths. 
Although the WHO stated that the Ebola epidemic in West Africa no 
longer represents a Public Health Emergency of International Concern, 
since Guinea, Liberia, and Sierra are now capable of controlling and 
maintaining further small outbreaks, lare-ups still occur, most recently, 
on 4th April when two new cases were reported in Liberia (www.who.int).
Our understanding of the Ebolavirus biology remains limited. A 
major reason for this is that Ebolaviruses are safety level 4 pathogens 
and that there is only a very limited number of appropriate containment 
level laboratories. Computational studies were suggested as a strategy to 
increase research on Ebolaviruses and to complement wet laboratory, 
clinical, and epidemiological studies. he International Society of 
Computational Biology (ISCB) acknowledged this and launched an award 
for computational biology studies on Ebola [1].
he performance of meaningful computational research depends 
on the availability of suicient data for analysis. Indeed, the analysis of 
isolates from the current Ebola outbreak in West Africa resulted in a steep 
increase in sequencing data [2-8] that enable computational investigation.
A number of computational studies have already made use of these data 
in order to gain novel insights into the Ebolavirus biology. Two studies used 
similar bioinformatics approaches to identify potential microRNAs [9,10]. 
Further, two studies determined speciic signatures as potential vaccine, 
diagnostic, or therapeutic targets [11,12]. Wet laboratory experiments will 
now be needed to validate these computational predictions.
he need for a close interaction between computational and wet 
laboratories is particularly emphasised by two recent studies that 
investigated the diferencesin human pathogenicity between the 
Ebolavirus species. he two studies used similar approaches but came to 
diferent results [13,14]. Both studies compared the genomes of the four 
human pathogenic Ebolavirus species Zaire ebolavirus (type virus: Ebola 
virus), Sudan ebolavirus (type virus: Sudan virus), Bundibugyo ebolavirus 
(type virus: Bundibugyo virus), and Tai Forest ebolavirus (type virus: Tai 
Forest virus) to the available genomes of the Reston virus (species Reston 
ebolavirus) [13,14] that causes disease in primates but not in humans [15].
In order to identify variations that may cause the diferences in human 
pathogenicity, Cong et al. [13] identiied positions in Ebolavirus proteins 
that are diferently conserved between human-pathogenic Ebolaviruses 
and Reston viruses. hey could map 43 out of 215 diferentially conserved 
positions onto structures or models of Ebolavirus proteins. his 
information was combined with ananalysis of the variations between 
human and primate host cell proteins that are known to interact with 
Ebolavirus proteins. he authors found diferences in the Ebolavirus 
VP24 protein that may afect the interaction of VP24 and KPNA5 and in 
turn the VP24-mediated inhibition of STAT1 activation and interferon 
signalling. However, they concluded that diferences in VP24, VP30, 
and VP40 are unlikely to be responsible for the diferences in human 
pathogenicity because the host proteins that interact with these virus 
proteins are very similar. he host interaction partners of GP and VP35 
displayed greater variability, and Cong et al. [13] thus, suggested that a 
cluster of diferentially conserved residues in the C terminal region of 
GP and a cluster of changes in VP35 may cause the diferences in human 
pathogenicity between the Ebolavirus species.
In the second study, we identiied speciicity determining positions 
(SDPs) [16] to identify positions that are diferentially conserved between 
the sequences of human pathogenic Ebolaviruses and Reston viruses [14]. 
47 out of 189 SDPs could be modelled onto protein structuresor models 
(generated using Phyre2 [17,18]) resulting in eight SDPs that potentially 
modify protein stability (2) or protein-protein interactions (6) [14]. Four 
of these SDPs occurred in VP24 with three of them being locatedin the 
VP24-KPNA5 binding site. A comparison of the three SDPs in the VP24-
KPNA5 binding site with Ebola virus VP24 residues that when mutated 
are known to decrease VP24 binding to KPNA5 and in turn to impair the 
capacity of Ebola virus VP24 to inhibit interferon signalling, suggestedthat 
Reston virus VP24 is less efective in antagonising the interferon response 
in human cells than Ebola virus VP24. If this interpretation is correct, few 
mutations in VP24 may result in a human pathogenic Reston virus. Hence, 
our predictions difer substantially from those of Cong et al. [13,14].
In conclusion, computational studies can provide novel insights into 
the biology of safety level 4 pathogens like Ebolaviruses for which wet lab 
research is limited to a small number of high containment laboratories. 
However, to achieve their full potential computational approaches require 
exchange with wet laboratory researchers. Only if wet laboratory scientists 
take computational predictions into accountwhen planning their 
experiments and report their indings, computational researchers will be 
able to improve the predictive power and accuracy of their methods in an 
iterative approach. Whether this will happen will depend on the open-
mindedness, tolerance, patience, curiosity, and preparedness to leave the 
comfort zone on both sides. Nevertheless, we are convinced that this is 
worth the efort because it will enable us as research community to make 
optimal use of all available resources.
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